Characterization of chronic myelomonocytic leukemia with TP53 mutations

Leuk Res. 2018 Jul:70:97-99. doi: 10.1016/j.leukres.2018.05.012. Epub 2018 May 31.

Authors

Wei Wang¹, Mark J Routbort², Sanam Loghavi², Zhenya Tang², L Jeffrey Medeiros², Sa A Wang²

Affiliations

¹ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: [email protected].
² Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

PMID: 29908419
DOI: 10.1016/j.leukres.2018.05.012

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Biomarkers
Female
Genetic Association Studies* / methods
Genetic Predisposition to Disease*
Humans
Leukemia, Myelomonocytic, Chronic / diagnosis*
Leukemia, Myelomonocytic, Chronic / genetics*
Male
Middle Aged
Mutation*
Retrospective Studies
Tumor Suppressor Protein p53 / genetics*

Substances

Biomarkers
Tumor Suppressor Protein p53